http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103131736-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
filingDate | 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103131736-B |
titleOfInvention | The preparations and applicatio of high purity lyso-phosphatidylcholine |
abstract | The invention provides a kind of method effectively preparing high purity lyso-phosphatidylcholine newly, and use high purity lyso-phosphatidylcholine to prevent and/or treat the purposes of metabolic osteopathy.This novel processing step uses phosphatidylcholine to be converted into lyso-phosphatidylcholine under Phospholipase A2 catalysis, in conversion process, adds a kind of novel Phospholipase A2 active reinforcing agent.Decrease the consumption of Phospholipase A2, improve the yield of lyso-phosphatidylcholine, high purity lyso-phosphatidylcholine can be prepared.The high purity lyso-phosphatidylcholine of preparation can be used for the pharmaceutical composition of prevention/and treatment metabolic osteopathy. |
priorityDate | 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.